Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Shukra Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceuticals Products.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On January 9, 2025. | Download
Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On January 9, 2025. | Download
Final • Div/Share: ₹ 1
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant